Rates of inhibitor development in previously untreated patients with severe hemophilia A treated with plasma-derived or recombinant Factor VIII: no proof of difference or proof of no difference? [Letter to the Editor] - Messori, A; Fadda, V; Maratea, D; Trippoli, S (Semin Thromb Hemost, 2014)